MilliporeSigma invests US$ 76 million to expand ADC manufacturing in North America
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
Reinforces position as first commercially approved contract development and manufacturing organization (CDMO) for ADCs in North America
Potential to optimize and build on the synergies in commercial operations, distribution, manufacturing, supply chain etc.
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
We now rank 3rd in pharmaceutical production by volume and 14th by value
Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results
The trial met its primary and secondary endpoints demonstrating that administration of a 3-dose regimen of GARDASIL 9
Phase 3 clinical trial designed to evaluate the safety and efficacy of tivozanib in combination with nivolumab
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
These accolades highlight our unwavering commitment to maintaining the highest safety standards
Coveris’ security labels also work seamlessly with self-checkouts where around 80% of retail sales now typically occur
Subscribe To Our Newsletter & Stay Updated